ANGELI, Piero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.010
EU - Europa 3.515
AS - Asia 2.680
SA - Sud America 317
Continente sconosciuto - Info sul continente non disponibili 164
AF - Africa 109
OC - Oceania 8
Totale 14.803
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.715
CN - Cina 1.157
RU - Federazione Russa 760
DE - Germania 717
SG - Singapore 714
IT - Italia 495
SE - Svezia 264
BR - Brasile 253
PL - Polonia 240
GB - Regno Unito 236
CA - Canada 226
FR - Francia 221
UA - Ucraina 219
HK - Hong Kong 207
VN - Vietnam 187
FI - Finlandia 152
TR - Turchia 123
ZA - Sudafrica 83
KR - Corea 68
BD - Bangladesh 48
IE - Irlanda 46
AR - Argentina 40
BE - Belgio 38
CZ - Repubblica Ceca 38
EU - Europa 36
IN - India 36
JP - Giappone 28
MX - Messico 28
IR - Iran 22
IQ - Iraq 18
NL - Olanda 18
ES - Italia 11
PK - Pakistan 9
RO - Romania 9
HN - Honduras 8
SA - Arabia Saudita 8
CR - Costa Rica 7
EC - Ecuador 7
RS - Serbia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
GR - Grecia 6
ID - Indonesia 6
LT - Lituania 6
MA - Marocco 6
AU - Australia 5
GE - Georgia 5
GT - Guatemala 5
SV - El Salvador 5
AT - Austria 4
CO - Colombia 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
KE - Kenya 4
OM - Oman 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MY - Malesia 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
GP - Guadalupe 2
HR - Croazia 2
JM - Giamaica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
KH - Cambogia 1
KI - Kiribati 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
Totale 14.668
Salva come PNG Salva come JPEG
Città #
Dallas 721
Ashburn 664
Woodbridge 540
Jacksonville 529
Chandler 435
San Jose 389
Fairfield 377
Singapore 363
Houston 293
Ann Arbor 286
Council Bluffs 263
Wilmington 248
Boardman 210
Hong Kong 197
Beijing 194
Nanjing 184
Seattle 182
Los Angeles 133
Toronto 129
Cambridge 128
Warsaw 128
Düsseldorf 119
New York 115
Kraków 108
The Dalles 104
Istanbul 98
Columbus 84
San Mateo 83
Johannesburg 76
Buffalo 72
Dearborn 70
Helsinki 67
Seoul 67
Princeton 66
Lawrence 65
Tongling 65
Lachine 64
Nanchang 64
Santa Clara 62
Lauterbourg 61
Ho Chi Minh City 58
Moscow 53
Ogden 53
Dublin 46
Hanoi 46
Kunming 46
Chicago 45
Milan 45
Shanghai 42
Munich 38
Camerino 37
Hebei 37
Guangzhou 36
London 35
Brussels 34
Tianjin 33
Phoenix 30
Shenyang 30
Orem 27
Tokyo 27
Brno 24
São Paulo 24
Jiaxing 23
Denver 22
Philadelphia 22
San Diego 21
Changsha 20
Hangzhou 19
Redwood City 19
Orange 18
Venezia 18
Venice 18
Washington 18
Bremen 16
Stockholm 16
Chennai 15
Frankfurt am Main 15
Wuhan 15
Brooklyn 14
Buenos Aires 14
Newark 14
Perugia 14
Turku 14
Hefei 13
Zhengzhou 13
Jinan 12
Montreal 12
St Louis 12
Verona 12
Ningbo 11
Olomouc 11
Rome 11
Shenzhen 11
Atlanta 10
Falls Church 10
Lanzhou 10
St Petersburg 10
Amsterdam 9
Auburn Hills 9
Boston 9
Totale 9.499
Salva come PNG Salva come JPEG
Nome #
“1,3 Oxathiolane Muscarinic Ligands Modified at the Cationic Head”. 580
1,3-Dioxolane-based ligands as a novel class of alpha(1)-adrenoceptor antagonists 549
1,3-Dioxolane-based ligands as rigid analogues of Naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. 540
Overview on Radiolabel-Free in Vitro Assays for GPCRs 418
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 337
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 298
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 280
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 280
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 266
"[4-[[N-(3-Chlorophenyl)carbamoyl]-2-butynyl]-trimethylammonium (McN-A-343)-Related Compounds. Effect of the Butynyl Chain Inclusion into an Aromatic Unit of the Potency for Muscarinic Receptors 259
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 259
Doxazosin-Related a1-Adrenoceptor Antagonists With Prostate Antitumor Activity 250
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 248
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 242
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 241
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 241
Antimuscarinic activity in a series of 2-substituted 1,3-dioxolanes 240
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 233
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 233
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed rat Preparation 231
Analogues of Prazosin That Bear a Benextramine-Related Polyamine Backbone Exhibit Different Antagonism toward alpha1-Adrenoceptor Subtypes 230
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 227
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine 222
Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity 220
“Synthesis and Pharmacological Evaluation of Enantiomerically Pure 4-Deoxy-4-Fluoro-Muscarines”. 220
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 219
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure 218
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 218
“Dialkylaminoalkyl Esters of 2,2 Diphenyl-2-Alkylthioacetic Acids: A New Class of Potent and Functionally Selective Muscarinic Antagonists”. 216
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 215
Discovery of a new series of 5-HT1A receptor agonists 214
“N,N-diethylaminoethanol and N-methyl-4-piperidinol Esters of 2,2-diphenyl-2-Ethylthioacetic Acid as Potent and Selective Muscarinic Antagonist”. 213
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 212
Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral alpha-adrenoreceptors 209
Synthesis and pharmacological characterization of new chiral derivatives of muscarine and allo-muscarine 203
Searching for cyclazosin analogues as alfa1B-adrenoceptor antagonists 200
“Pharmacological Characterization of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparations” 199
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 199
The Camerino symposium series (1978-2013): a privileged observatory of receptorology development 197
3-arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands 194
Structure-activity relationships among novel phenoxybenzamine-related beta-chloroethylamines 194
Synthesis and Structure-Activity Relationship Studies in a Series of 2-Substituted 1,3-Dioxolanes Modified at the Cationic Head. 192
Polyamines may modulate both G protein-coupled receptors and G proteins. 191
SAR Studies on the Potent and Selective Muscarinic Antagonist 2-Ethylthio-2,2-diphenylacetic Acid N,N-Diethylaminoethyl Ester 190
. “Synthesis, Pharmacological “Evaluation and Selectivity Profile of Isomeric 2-Phenyl-2-Cyclohexyl-4-[(Dimethylamino)Methyl]-1,3-Dithiolane Methiodides, as Potent Antimuscarinic Agents”. 189
Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol 187
Receptors in neurodegenerative diseases, muscarinic cholinergic receptors 185
New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: High affinity ligands for the alpha-adrenoceptor subtypes 185
Synthesis and alpha-Adrenoceptor Blocking Activity of the Enantiomers of Benzyl- (2-chloroethyl)-[2-(2-methoxyphenoxy)-1-methylethyl] amine Hydrochloride 184
In vitro metabolism studies of new adenosine A(2A) receptor antagonists 178
Trekking through receptor chemistry 177
“Enantiomers of 8-(tert-butylamino-2-hydroxypropoxy) 3,4-dihydro-3-oxo-2H-(1,4) Benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity“. 176
Byciclic dioxolanes as potential antimuscarinic agents 176
“Pharmacological Characterization of Chiral Muscarinic Antagonists cis -2- phenyl-2- cyclohexyl-r-5-[(dimethylamino)-methyl]-1,3-oxathiolane-3-Oxide methiodides”. 174
Synthesis and α(1)-adrenoceptor antagonist activity of tamsulosin analogues 171
Alpha 1-adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety 167
Structure-Activity Relationships in 2,2-Diphenyl-2-ethylthioacetic Acid Esters: Unexpected Agonist Activity in a Series of Muscarinic Antagonists. 165
Modulation of receptors and G-proteins 156
Pharmacological profile of enantiomerically pure chiral muscarinic agonists - desoxymuscarines 155
Structure-activity relationships among methoctramine-related polymethylene tetraamines. Chain-length and substituent effects on M2-muscarinic receptor blocking activity. 153
null 149
Pentatomic cyclic agonists and muscarinic receptors: a 30-year review 137
Stereoselettive Increase in Cholinergic Transmission by R-(+)-hyoscyamine 135
Polymethylene tetraamines as muscarinc receptor probes 131
Trends in drug Research 122
Synthesis, Absolute Configuration and Antimuscarinic Activity of the Enantiomers of [1-(2,2-Diphenyl-[1,3]dioxolan-4-yl)-ethyl]-dimethyl-amine. 114
Totale 14.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 0 0 61 52 32 18 52 49 85 71 89
2022/20231.042 110 43 41 175 127 151 8 72 155 55 78 27
2023/2024700 103 42 56 12 25 40 28 20 67 36 28 243
2024/20252.161 74 59 183 103 44 118 246 574 145 144 142 329
2025/20263.530 200 233 833 441 358 272 443 202 141 166 147 94
2026/20271.023 184 84 270 485 0 0 0 0 0 0 0 0
Totale 14.803